▾Topical minoxidil does little for baldness
Author information unavailable
Abstract
Author information unavailable
Abstract
Most patients taking oral minoxidil for hypertension develop hypertrichosis and in a few, male-pattern baldness has improved.1 Topical formulations attempt to stimulate hair growth without the systemic effects; a 2% minoxidil solution (Regaine, Upjohn) has been marketed in the UK since May 1988 for male-pattern or ‘common’ baldness. It is not licensed for use by women or in other forms of baldness and is only available on private prescription.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Most patients taking oral minoxidil for hypertension develop hypertrichosis and in a few, male-pattern baldness has improved.1 Topical formulations attempt to stimulate hair growth without the systemic effects; a 2% minoxidil solution (Regaine, Upjohn) has been marketed in the UK since May 1988 for male-pattern or ‘common’ baldness. It is not licensed for use by women or in other forms of baldness and is only available on private prescription.
Key concepts: Minoxidil, Male-pattern baldness, Medicine, Dermatology, Hypertrichosis, Medical prescription, Scalp, Pharmacology